High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004
A nationwide antimicrobial resistance surveillance has been conducted since 1997 in Korea. In this study, susceptibility test data generated in 2004 by KONSAR group hospitals were analyzed and compared to those at a commercial laboratory. In hospitals, the rank orders of organisms in 2004 were ident...
Gespeichert in:
| Veröffentlicht in: | Yonsei medical journal 2006-10, Vol.47 (5), p.634-645 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 645 |
|---|---|
| container_issue | 5 |
| container_start_page | 634 |
| container_title | Yonsei medical journal |
| container_volume | 47 |
| creator | Lee, Kyungwon Lim, Chang Hyun Cho, Ji Hyun Lee, Wee Gyo Uh, Young Kim, Hwi Jun Yong, Dongeun Chong, Yunsop |
| description | A nationwide antimicrobial resistance surveillance has been conducted since 1997 in Korea. In this study, susceptibility test data generated in 2004 by KONSAR group hospitals were analyzed and compared to those at a commercial laboratory. In hospitals, the rank orders of organisms in 2004 were identical to those in 2003. The most prevalent species was Staphylococcus aureus (20.2%) in hospitals, but Escherichia coli (29.7%) in the commercial laboratory. The proportions of Enterococcus faecium to all isolates of Enterococcus faecalis plus E. faecium were 47.2% in hospitals and 24.9% in the commercial laboratory. The mean resistance rates of significant antimicrobial-organism combinations in hospitals were: oxacillin-resistant S. aureus (68%), oxacillin-resistant (penicillin- nonsusceptible) Streptococcus pneumoniae (68%), vancomycin-resistant E. faecium (25%), cefotaxime-resistant E. coli (14%), ceftazidime- and cefoxitin-resistant Klebsiella pneumoniae (34% and 32%, respectively), and imipenem-resistant Acinetobacter spp. and Pseudomonas aeruginosa (17% and 24%, respectively). In conclusion, oxacillin-resistant staphylococci, expanded-spectrum cephalosporin-resistant K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa were prevalent in 2004. Increasing trends were observed for vancomycin-resistant E. faecium, cefoxitin- resistant E. coli and K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa. Certain antimicrobial- organism combinations were also prevalent among the commercial laboratory-tested strains. |
| doi_str_mv | 10.3349/ymj.2006.47.5.634 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2687749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69000199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-2be3bfed7d7e7a9d8ab431dc8cbe729cca4aad7b924fb83df2df05442b3c9f313</originalsourceid><addsrcrecordid>eNpVkc1u1DAURi0EokPhAdggr9glOLETj1kgjSqgaCqK-Flb1_bN1FViBzupVB6LJyRpR1BWXtzvfL72IeRlxUrOhXpzO1yXNWNtKWTZlC0Xj8imUrItasHlY7JhTcWLRqr2hDzL-ZqxWlasfkpOKsnatmFyQ36f-8MVHRPeQI_BIo0dtdhN8Ms7P2CRMPs8QZjovkeTPfY90DHgPMTgASkER32wCSHfsX7wIwYcHoBfMs4uLnnIFDDNBx9ihjtyZ33AKRqwEyaax7Fcyug-LnVvKdD95edvu6_LdvGQYFhHy2vFc_Kkgz7ji-N5Sn58eP_97Ly4uPz46Wx3UViu5FTUBrnp0EknUYJyWzCCV85urUFZK2tBADhpVC06s-Wuq13HGiFqw63qeMVPybv73nE2AzqLYUrQ6zH5AdKtjuD1_5Pgr_Qh3ui63Uop1FLw-liQ4s8Z86QHn-36gwHjnHWrGGOVWoPVfdCmmHPC7u8lFdOrab2Y1qtpLaRu9GJ6YV493O4fcVTL_wDJKKth</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69000199</pqid></control><display><type>article</type><title>High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004</title><source>KoreaMed Synapse</source><source>MEDLINE</source><source>KoreaMed Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Lee, Kyungwon ; Lim, Chang Hyun ; Cho, Ji Hyun ; Lee, Wee Gyo ; Uh, Young ; Kim, Hwi Jun ; Yong, Dongeun ; Chong, Yunsop</creator><creatorcontrib>Lee, Kyungwon ; Lim, Chang Hyun ; Cho, Ji Hyun ; Lee, Wee Gyo ; Uh, Young ; Kim, Hwi Jun ; Yong, Dongeun ; Chong, Yunsop ; KONSAR Group ; the KONSAR group</creatorcontrib><description>A nationwide antimicrobial resistance surveillance has been conducted since 1997 in Korea. In this study, susceptibility test data generated in 2004 by KONSAR group hospitals were analyzed and compared to those at a commercial laboratory. In hospitals, the rank orders of organisms in 2004 were identical to those in 2003. The most prevalent species was Staphylococcus aureus (20.2%) in hospitals, but Escherichia coli (29.7%) in the commercial laboratory. The proportions of Enterococcus faecium to all isolates of Enterococcus faecalis plus E. faecium were 47.2% in hospitals and 24.9% in the commercial laboratory. The mean resistance rates of significant antimicrobial-organism combinations in hospitals were: oxacillin-resistant S. aureus (68%), oxacillin-resistant (penicillin- nonsusceptible) Streptococcus pneumoniae (68%), vancomycin-resistant E. faecium (25%), cefotaxime-resistant E. coli (14%), ceftazidime- and cefoxitin-resistant Klebsiella pneumoniae (34% and 32%, respectively), and imipenem-resistant Acinetobacter spp. and Pseudomonas aeruginosa (17% and 24%, respectively). In conclusion, oxacillin-resistant staphylococci, expanded-spectrum cephalosporin-resistant K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa were prevalent in 2004. Increasing trends were observed for vancomycin-resistant E. faecium, cefoxitin- resistant E. coli and K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa. Certain antimicrobial- organism combinations were also prevalent among the commercial laboratory-tested strains.</description><identifier>ISSN: 0513-5796</identifier><identifier>EISSN: 1976-2437</identifier><identifier>DOI: 10.3349/ymj.2006.47.5.634</identifier><identifier>PMID: 17066507</identifier><language>eng</language><publisher>Korea (South): Yonsei University College of Medicine</publisher><subject>Acinetobacter - drug effects ; Acinetobacter - isolation & purification ; Anti-Bacterial Agents - pharmacology ; Ceftazidime - pharmacology ; Drug Resistance, Multiple, Bacterial ; Gammaproteobacteria - drug effects ; Gammaproteobacteria - isolation & purification ; Hospitals ; Imipenem - pharmacology ; Klebsiella pneumoniae - drug effects ; Klebsiella pneumoniae - isolation & purification ; Korea ; Laboratories ; Microbial Sensitivity Tests ; Original ; Pseudomonas aeruginosa - drug effects ; Pseudomonas aeruginosa - isolation & purification</subject><ispartof>Yonsei medical journal, 2006-10, Vol.47 (5), p.634-645</ispartof><rights>Copyright © 2006 The Yonsei University College of Medicine 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-2be3bfed7d7e7a9d8ab431dc8cbe729cca4aad7b924fb83df2df05442b3c9f313</citedby><cites>FETCH-LOGICAL-c397t-2be3bfed7d7e7a9d8ab431dc8cbe729cca4aad7b924fb83df2df05442b3c9f313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687749/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687749/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17066507$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Kyungwon</creatorcontrib><creatorcontrib>Lim, Chang Hyun</creatorcontrib><creatorcontrib>Cho, Ji Hyun</creatorcontrib><creatorcontrib>Lee, Wee Gyo</creatorcontrib><creatorcontrib>Uh, Young</creatorcontrib><creatorcontrib>Kim, Hwi Jun</creatorcontrib><creatorcontrib>Yong, Dongeun</creatorcontrib><creatorcontrib>Chong, Yunsop</creatorcontrib><creatorcontrib>KONSAR Group</creatorcontrib><creatorcontrib>the KONSAR group</creatorcontrib><title>High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004</title><title>Yonsei medical journal</title><addtitle>Yonsei Med J</addtitle><description>A nationwide antimicrobial resistance surveillance has been conducted since 1997 in Korea. In this study, susceptibility test data generated in 2004 by KONSAR group hospitals were analyzed and compared to those at a commercial laboratory. In hospitals, the rank orders of organisms in 2004 were identical to those in 2003. The most prevalent species was Staphylococcus aureus (20.2%) in hospitals, but Escherichia coli (29.7%) in the commercial laboratory. The proportions of Enterococcus faecium to all isolates of Enterococcus faecalis plus E. faecium were 47.2% in hospitals and 24.9% in the commercial laboratory. The mean resistance rates of significant antimicrobial-organism combinations in hospitals were: oxacillin-resistant S. aureus (68%), oxacillin-resistant (penicillin- nonsusceptible) Streptococcus pneumoniae (68%), vancomycin-resistant E. faecium (25%), cefotaxime-resistant E. coli (14%), ceftazidime- and cefoxitin-resistant Klebsiella pneumoniae (34% and 32%, respectively), and imipenem-resistant Acinetobacter spp. and Pseudomonas aeruginosa (17% and 24%, respectively). In conclusion, oxacillin-resistant staphylococci, expanded-spectrum cephalosporin-resistant K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa were prevalent in 2004. Increasing trends were observed for vancomycin-resistant E. faecium, cefoxitin- resistant E. coli and K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa. Certain antimicrobial- organism combinations were also prevalent among the commercial laboratory-tested strains.</description><subject>Acinetobacter - drug effects</subject><subject>Acinetobacter - isolation & purification</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Ceftazidime - pharmacology</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>Gammaproteobacteria - drug effects</subject><subject>Gammaproteobacteria - isolation & purification</subject><subject>Hospitals</subject><subject>Imipenem - pharmacology</subject><subject>Klebsiella pneumoniae - drug effects</subject><subject>Klebsiella pneumoniae - isolation & purification</subject><subject>Korea</subject><subject>Laboratories</subject><subject>Microbial Sensitivity Tests</subject><subject>Original</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Pseudomonas aeruginosa - isolation & purification</subject><issn>0513-5796</issn><issn>1976-2437</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc1u1DAURi0EokPhAdggr9glOLETj1kgjSqgaCqK-Flb1_bN1FViBzupVB6LJyRpR1BWXtzvfL72IeRlxUrOhXpzO1yXNWNtKWTZlC0Xj8imUrItasHlY7JhTcWLRqr2hDzL-ZqxWlasfkpOKsnatmFyQ36f-8MVHRPeQI_BIo0dtdhN8Ms7P2CRMPs8QZjovkeTPfY90DHgPMTgASkER32wCSHfsX7wIwYcHoBfMs4uLnnIFDDNBx9ihjtyZ33AKRqwEyaax7Fcyug-LnVvKdD95edvu6_LdvGQYFhHy2vFc_Kkgz7ji-N5Sn58eP_97Ly4uPz46Wx3UViu5FTUBrnp0EknUYJyWzCCV85urUFZK2tBADhpVC06s-Wuq13HGiFqw63qeMVPybv73nE2AzqLYUrQ6zH5AdKtjuD1_5Pgr_Qh3ui63Uop1FLw-liQ4s8Z86QHn-36gwHjnHWrGGOVWoPVfdCmmHPC7u8lFdOrab2Y1qtpLaRu9GJ6YV493O4fcVTL_wDJKKth</recordid><startdate>20061031</startdate><enddate>20061031</enddate><creator>Lee, Kyungwon</creator><creator>Lim, Chang Hyun</creator><creator>Cho, Ji Hyun</creator><creator>Lee, Wee Gyo</creator><creator>Uh, Young</creator><creator>Kim, Hwi Jun</creator><creator>Yong, Dongeun</creator><creator>Chong, Yunsop</creator><general>Yonsei University College of Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20061031</creationdate><title>High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004</title><author>Lee, Kyungwon ; Lim, Chang Hyun ; Cho, Ji Hyun ; Lee, Wee Gyo ; Uh, Young ; Kim, Hwi Jun ; Yong, Dongeun ; Chong, Yunsop</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-2be3bfed7d7e7a9d8ab431dc8cbe729cca4aad7b924fb83df2df05442b3c9f313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Acinetobacter - drug effects</topic><topic>Acinetobacter - isolation & purification</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Ceftazidime - pharmacology</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>Gammaproteobacteria - drug effects</topic><topic>Gammaproteobacteria - isolation & purification</topic><topic>Hospitals</topic><topic>Imipenem - pharmacology</topic><topic>Klebsiella pneumoniae - drug effects</topic><topic>Klebsiella pneumoniae - isolation & purification</topic><topic>Korea</topic><topic>Laboratories</topic><topic>Microbial Sensitivity Tests</topic><topic>Original</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Pseudomonas aeruginosa - isolation & purification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Kyungwon</creatorcontrib><creatorcontrib>Lim, Chang Hyun</creatorcontrib><creatorcontrib>Cho, Ji Hyun</creatorcontrib><creatorcontrib>Lee, Wee Gyo</creatorcontrib><creatorcontrib>Uh, Young</creatorcontrib><creatorcontrib>Kim, Hwi Jun</creatorcontrib><creatorcontrib>Yong, Dongeun</creatorcontrib><creatorcontrib>Chong, Yunsop</creatorcontrib><creatorcontrib>KONSAR Group</creatorcontrib><creatorcontrib>the KONSAR group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Yonsei medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Kyungwon</au><au>Lim, Chang Hyun</au><au>Cho, Ji Hyun</au><au>Lee, Wee Gyo</au><au>Uh, Young</au><au>Kim, Hwi Jun</au><au>Yong, Dongeun</au><au>Chong, Yunsop</au><aucorp>KONSAR Group</aucorp><aucorp>the KONSAR group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004</atitle><jtitle>Yonsei medical journal</jtitle><addtitle>Yonsei Med J</addtitle><date>2006-10-31</date><risdate>2006</risdate><volume>47</volume><issue>5</issue><spage>634</spage><epage>645</epage><pages>634-645</pages><issn>0513-5796</issn><eissn>1976-2437</eissn><abstract>A nationwide antimicrobial resistance surveillance has been conducted since 1997 in Korea. In this study, susceptibility test data generated in 2004 by KONSAR group hospitals were analyzed and compared to those at a commercial laboratory. In hospitals, the rank orders of organisms in 2004 were identical to those in 2003. The most prevalent species was Staphylococcus aureus (20.2%) in hospitals, but Escherichia coli (29.7%) in the commercial laboratory. The proportions of Enterococcus faecium to all isolates of Enterococcus faecalis plus E. faecium were 47.2% in hospitals and 24.9% in the commercial laboratory. The mean resistance rates of significant antimicrobial-organism combinations in hospitals were: oxacillin-resistant S. aureus (68%), oxacillin-resistant (penicillin- nonsusceptible) Streptococcus pneumoniae (68%), vancomycin-resistant E. faecium (25%), cefotaxime-resistant E. coli (14%), ceftazidime- and cefoxitin-resistant Klebsiella pneumoniae (34% and 32%, respectively), and imipenem-resistant Acinetobacter spp. and Pseudomonas aeruginosa (17% and 24%, respectively). In conclusion, oxacillin-resistant staphylococci, expanded-spectrum cephalosporin-resistant K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa were prevalent in 2004. Increasing trends were observed for vancomycin-resistant E. faecium, cefoxitin- resistant E. coli and K. pneumoniae, and imipenem-resistant Acinetobacter spp. and P. aeruginosa. Certain antimicrobial- organism combinations were also prevalent among the commercial laboratory-tested strains.</abstract><cop>Korea (South)</cop><pub>Yonsei University College of Medicine</pub><pmid>17066507</pmid><doi>10.3349/ymj.2006.47.5.634</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0513-5796 |
| ispartof | Yonsei medical journal, 2006-10, Vol.47 (5), p.634-645 |
| issn | 0513-5796 1976-2437 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2687749 |
| source | KoreaMed Synapse; MEDLINE; KoreaMed Open Access; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
| subjects | Acinetobacter - drug effects Acinetobacter - isolation & purification Anti-Bacterial Agents - pharmacology Ceftazidime - pharmacology Drug Resistance, Multiple, Bacterial Gammaproteobacteria - drug effects Gammaproteobacteria - isolation & purification Hospitals Imipenem - pharmacology Klebsiella pneumoniae - drug effects Klebsiella pneumoniae - isolation & purification Korea Laboratories Microbial Sensitivity Tests Original Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - isolation & purification |
| title | High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A43%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20prevalence%20of%20ceftazidime-resistant%20Klebsiella%20pneumoniae%20and%20increase%20of%20imipenem-resistant%20Pseudomonas%20aeruginosa%20and%20Acinetobacter%20spp.%20in%20Korea:%20a%20KONSAR%20program%20in%202004&rft.jtitle=Yonsei%20medical%20journal&rft.au=Lee,%20Kyungwon&rft.aucorp=KONSAR%20Group&rft.date=2006-10-31&rft.volume=47&rft.issue=5&rft.spage=634&rft.epage=645&rft.pages=634-645&rft.issn=0513-5796&rft.eissn=1976-2437&rft_id=info:doi/10.3349/ymj.2006.47.5.634&rft_dat=%3Cproquest_pubme%3E69000199%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69000199&rft_id=info:pmid/17066507&rfr_iscdi=true |